Article

Finding the EXTRA in an ordinary day

Author(s):

suzanne lindley blog image

It's an ordinary day. The fatigue from my RFA (radiofrequency ablation) last month has subsided. The effects of chemo last week have disappeared and there are no appointments, labs or scans on my calendar for the next two weeks. Life is about as "normal" as possible for someone living with metastatic cancer. As I watch the tree branches rock and sway with the swirl of a spring wind through the kitchen window. I dream of things to do and adventures to take. I dream of graduations, weddings, and the beginning of kindergarten...I dream of springtime walks and the splendor of a sunset...I dream of the ocean and hope in the sand...I dream of riding horseback across an open field...I dream of campfires and the magnificence of a moonlit night...I dream of raindrops and roses, sunshine and sailboats...I dream of Ronnie and walking hand in hand...I dream of friendship and laughter...I dream of magical memories of days gone by and of the mystery that tomorrow holds...And I know that held within these dreams are the simple things that add a little extra to make this ordinary day - truly EXTRAordinary.What will add the extra to your ordinary today?

Related Videos
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Image of man with grey hair.
Related Content